Wang, Lisa L.

Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

Ahmed, N., Brawley, V. S., Hegde, M., Robertson, C., Ghazi, A., Gerken, C., Liu, E., Dakhova, O., Ashoori, A., Corder, A., et al. (2015) · Journal of Clinical Oncology

CAR-T cell therapy researchImmunotherapy and Immune Responses

Cited by 1,004

Osteosarcoma: Molecular Pathogenesis and iPSC Modeling

Lin, Y.-H., Jewell, B. E., Gingold, J., Lu, L., Zhao, R., Wang, L. L., & Lee, D.-F. (2017) · Trends in Molecular Medicine

Sarcoma Diagnosis and TreatmentBone Tumor Diagnosis and Treatments

Cited by 150

RECQ DNA Helicases and Osteosarcoma

Lu, L., Jin, W., & Wang, L. L. (2020) · Advances in Experimental Medicine and Biology

DNA Repair MechanismsSarcoma Diagnosis and Treatment

Cited by 28